Wilmington Savings Fund Society FSB decreased its position in shares of Cigna Group (NYSE:CI – Free Report) by 35.2% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 10,205 shares of the health services provider’s stock after selling 5,535 shares during the quarter. Wilmington Savings Fund Society FSB’s holdings in Cigna Group were worth $2,942,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other hedge funds also recently added to or reduced their stakes in the company. Sunbelt Securities Inc. lifted its position in Cigna Group by 180.5% in the 3rd quarter. Sunbelt Securities Inc. now owns 488 shares of the health services provider’s stock valued at $141,000 after acquiring an additional 314 shares in the last quarter. Danske Bank A S purchased a new stake in Cigna Group during the 3rd quarter valued at $51,862,000. Integrated Investment Consultants LLC increased its holdings in shares of Cigna Group by 22.6% in the 3rd quarter. Integrated Investment Consultants LLC now owns 2,030 shares of the health services provider’s stock worth $585,000 after purchasing an additional 374 shares in the last quarter. Tcfg Wealth Management LLC raised its stake in shares of Cigna Group by 1,262.9% in the third quarter. Tcfg Wealth Management LLC now owns 10,699 shares of the health services provider’s stock worth $3,084,000 after purchasing an additional 9,914 shares during the last quarter. Finally, Financial Engines Advisors L.L.C. lifted its holdings in shares of Cigna Group by 235.9% during the third quarter. Financial Engines Advisors L.L.C. now owns 2,963 shares of the health services provider’s stock valued at $854,000 after purchasing an additional 2,081 shares in the last quarter. 86.99% of the stock is currently owned by hedge funds and other institutional investors.
Cigna Group Stock Performance
CI opened at $264.87 on Thursday. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.74 and a current ratio of 0.74. The stock has a market capitalization of $69.80 billion, a price-to-earnings ratio of 11.94, a PEG ratio of 0.91 and a beta of 0.27. The company has a fifty day moving average of $278.57 and a 200 day moving average of $282.09. Cigna Group has a fifty-two week low of $239.51 and a fifty-two week high of $350.00.
Cigna Group Increases Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Thursday, March 19th. Shareholders of record on Thursday, March 5th will be given a dividend of $1.56 per share. This represents a $6.24 dividend on an annualized basis and a yield of 2.4%. This is a boost from Cigna Group’s previous quarterly dividend of $1.51. The ex-dividend date is Thursday, March 5th. Cigna Group’s dividend payout ratio (DPR) is currently 28.13%.
Insider Activity at Cigna Group
In related news, insider Everett Neville sold 1,719 shares of Cigna Group stock in a transaction dated Monday, March 2nd. The shares were sold at an average price of $288.91, for a total transaction of $496,636.29. Following the completion of the transaction, the insider directly owned 5,670 shares of the company’s stock, valued at approximately $1,638,119.70. The trade was a 23.26% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Nicole S. Jones sold 2,307 shares of the business’s stock in a transaction on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total transaction of $666,515.37. Following the sale, the insider directly owned 32,647 shares of the company’s stock, valued at $9,432,044.77. This represents a 6.60% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 0.70% of the stock is owned by company insiders.
Analyst Upgrades and Downgrades
A number of equities analysts have weighed in on the company. Royal Bank Of Canada decreased their target price on Cigna Group from $344.00 to $333.00 and set an “outperform” rating for the company in a research report on Friday, February 6th. Barclays lowered their price objective on shares of Cigna Group from $305.00 to $303.00 and set an “overweight” rating on the stock in a research report on Friday, February 6th. Robert W. Baird dropped their price target on Cigna Group from $372.00 to $315.00 and set an “outperform” rating on the stock in a research note on Thursday, December 11th. Wall Street Zen raised Cigna Group from a “hold” rating to a “buy” rating in a report on Saturday, February 7th. Finally, Mizuho set a $325.00 target price on Cigna Group in a research report on Friday, January 9th. One research analyst has rated the stock with a Strong Buy rating, seventeen have given a Buy rating and four have issued a Hold rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $333.11.
Check Out Our Latest Stock Report on Cigna Group
About Cigna Group
Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.
In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.
Recommended Stories
Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CI – Free Report).
Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.
